Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 90, 2019
Article
Trần Song Giang: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Hoàng Phương Nam: Bệnh viện Hữu Nghị Việt Tiệp Hải Phòng;
Published: November 1, 2019
Views: 69
References
1.
1. Gorenek B., Bax J., Boriani G. et al (2017). Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). EP Europace, 19(9), 1556–1578.
2.
2. FreedmanB.,BorianiG.,GlotzerT.V.etal.(2017). Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nature Reviews Cardiology, 14(12), 701–714.
3.
3. TrịnhVănNhị,TrầnSongGiang(2017)Nghiêncứutầnsuất rung nhĩ và nguy cơ tắc mạch ở bệnh nhân mangmáytạonhịpvĩnhviễnhai buồng. Luận văn Thạc sĩ chuyên ngành Tim Mạch, Trường Đại học Y Hà Nội.
4.
4. Benezet-MazuecosJ.,IglesiasJ.A.,CortésM.etal(2017). Silent atrial fibrillation in pacemaker early post-implantation period: an unintentionally provoked situation? EPEuropace, 20(5), 758–763.
5.
5. TaTienPhuoc,TrinhXuanHoi,PhamNhuHung(2003). Current status of pacemaker implantation in Viet nam. PACE, 26, 513-s129.
6.
6. HealeyJ.S.,ConnollyS.J.,GoldM.R.etal.(2012). Subclinical atrial fibrillation and the risk of stroke. NEngl J Med, 366(2), 120–129.
7.
\7. BorianiG.,GlotzerT.V.,SantiniM.etal.(2014). Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Euro Heart Journal, 35(8), 508–516
8.
8. M. O. Sweeney, A. J. Bank, E. Nsah et al (2007). Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. NewEnglandJournalofMedicine, 357 (10), 1000-1008.
9.
9. Orlov M.V., Ghali J.K., Araghi-Niknam M. et al. (2007). Asymptomatic Atrial Fibrillation in Pacemaker Recipients: Incidence, Progression, and Determinants Based on the Atrial High Rate Trial. Pacing and Clinical Electrophysiology, 30(3), 404–411.